The Misuse of Drugs Regulations 2001 No. 3998

SCHEDULE 5 U.K. CONTROLLED DRUGS EXCEPTED FROM THE PROHIBITION ON IMPORTATION, EXPORTATION AND POSSESSION [F1 (APART FROM NITROUS OXIDE)] AND SUBJECT TO THE REQUIREMENTS OF REGULATIONS 24 AND 26

Textual Amendments

F1 Words in Sch. 5 heading inserted (8.11.2023) by The Misuse of Drugs (England and Wales and Scotland) (Amendment) Regulations 2023 (S.I. 2023/1099), regs. 1(1), 8(a)

[F2 10.   A liquid formulation— U.K.

(a) containing cannabidiol obtained by extraction and purification from cannabis;

(b) where the concentration of—

(i) delta-9-tetrahydrocannabinol is not more than 0.1 milligram per millilitre; and

(ii) cannabidiol is 95-105 milligrams per millilitre;

(c) which is presented in a bottle, as an oral solution for oral administration; and

(d) which was approved for marketing by the European Commission on 19th September 2019. ]

Textual Amendments

F2 Sch. 5 para. 10 inserted (24.6.2020) by The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2020 (S.I. 2020/559), regs. 1(1), 2(4)